ICED£>~ :5 ,
aﬂtbcwxmoyowmj, W/mséw
Wynne/0.6 Ta i012— 3" gag/,3
Illllllllllllllllll |||||||||l|l|||||||||||l||lllllll

- ‘ i " MOS; 0550’)
|||||||||||||||||||l|||||I||||||||||||||||||||||l||||||||||| M C (WW
llllllllllllllllllllllllllllllllllllllllllllllllllllllllllll 5/7] I C}

UUID : CMBCSDE -DAC5 - ABM-A582 -8ABC766C529F
TCGA-VS-AQUP-OlA-PR Rﬁﬁﬁiizllted

 

III |
Ill |
III I

(MM/DDIYYYY)

PATHOLOGY REPORT:
PRIMARY SITE: Cervix

Inﬁltrative poorly differentiated carcinoma.
Note: Immunochemistry exam requested to improve evaluation.

Immunohistochemistry exam
Morphologic aspects associated with the immunohistochemistry proﬁle are
compatible with poorly differentiated endocervical mucinous adenocarcinoma.

 

 

